Top Markets
#1 bitcastle Token bitcastle Token +151.97%
#2 MowCat MowCat +87.43%
#3 MarsCoin MarsCoin +65.09%
#4 Palladium Network Palladium Network +53.12%
#5 Siren Siren +29.94%
#6 Bedrock Bedrock +29.43%
#7 Useless Coin Useless Coin +22.04%
#8 Asteroid Shiba Asteroid Shiba +17.54%
#9 edgeX edgeX +17.39%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
Coin of the day
bitcastle Token bitcastle Token
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Alar Pharmaceuticals Inc. Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.

6785
Clasificación en acciones #18598
Alar Pharmaceuticals Inc., a drug development company, focuses on developing... Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Precio por acción
$2.88
Capitalización bursátil
$192.66M
Cambio (1 día)
-0.55%
Cambio (1 año)
-59.61%
País
TW
Comercio Alar Pharmaceuticals Inc. (6785)

Categoría

Healthcare
Ganancias de Alar Pharmaceuticals Inc. (6785)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Alar Pharmaceuticals Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Alar Pharmaceuticals Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$1.21B -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT